ARCHIVES

States Sue Bristol-Myers Alleging Firm Took Illegal Actions To Block Taxol Competitors

This article is from The Cancer Letter archive.

Vol. 28 No. 23 | June 7, 2002

Download PDF Visit The Full Archive

Related Articles

CMS Allows Medicare Payment for Eloxatin, But Says Review of New Agents Likely

May 23, 2003

Owens Becomes President, NCCR

June 21, 1996

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

July 27, 2001

Sole Source Negotiations

October 17, 1975

Guest Editorial: Thoughts on Overusing Radiation in Medicine And Redeeming that Whole Body Scan Coupon

March 1, 2013

Former BMS Executive Bodnar Indicted.

April 25, 2008